Literature DB >> 2680523

Cardiovascular effects of endothelin in dogs: positive inotropic action in vivo.

T Kitayoshi1, T Watanabe, N Shimamoto.   

Abstract

Endothelin, administered i.v. to anesthetized dogs, dose dependently increased the cardiac output, left ventricular systolic pressure (LVSP), and maximum upstroke velocity (max dp/dt) of the LVSP for about 10 min without changing the heart rate. Thereafter the cardiac output decreased to below the control level but max dp/dt decreased to the control level. The arterial pressure and total peripheral resistance showed an initial, transient decrease followed by a sustained increase. These results suggest that endothelin has positive inotropic and long-lasting vasoconstrictive effects preceded by transient vasodilatation in vivo.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680523     DOI: 10.1016/0014-2999(89)90367-1

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

1.  Endothelin enhances the contractile responsiveness of adult rat ventricular myocytes to calcium by a pertussis toxin-sensitive pathway.

Authors:  R A Kelly; H Eid; B K Krämer; M O'Neill; B T Liang; M Reers; T W Smith
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 2.  Role of endothelin in hypertension.

Authors:  B K Krämer; M Ackermann; S M Kohler; G A Riegger
Journal:  Clin Investig       Date:  1994-01

3.  Endothelin receptors in the human coronary artery, ventricle and atrium. A quantitative autoradiographic analysis.

Authors:  W A Bax; A T Bruinvels; R J van Suylen; P R Saxena; D Hoyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

4.  Influence of endothelin 1 on human atrial myocardium--myocardial function and subcellular pathways.

Authors:  M Meyer; S Lehnart; B Pieske; K Schlottauer; S Munk; C Holubarsch; H Just; G Hasenfuss
Journal:  Basic Res Cardiol       Date:  1996 Jan-Feb       Impact factor: 17.165

5.  Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart.

Authors:  M G Peter; A P Davenport
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

6.  Effects of endothelin-1 on epicardial coronary tone, coronary blood flow, ECG-ST change and regional wall motion in anesthetized dogs.

Authors:  K Muramatsu; H Tomoike; Y Ohara; S Egashira; M Nakamura
Journal:  Heart Vessels       Date:  1991       Impact factor: 2.037

7.  Hemodynamic and inotropic effects of endothelin-1 in vivo.

Authors:  M E Beyer; S Nerz; B K Krämer; H M Hoffmeister
Journal:  Basic Res Cardiol       Date:  1994 Jan-Feb       Impact factor: 17.165

8.  Differences in regional vascular sensitivity to endothelin-1 between spontaneously hypertensive and normotensive Wistar-Kyoto rats.

Authors:  C E Wright; J R Fozard
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.